Current therapy of advanced cancers is based on several modalities including radiotherapy,
cytotoxic chemotherapy, molecularly targeted inhibitors and antibodies targeting immune …

Through the success of basic and disease-specific research, cancer survivors are one of the
largest growing subsets of individuals accessing the healthcare system. Interestingly …

Cardiotoxicity is a significant complication of chemotherapeutic agents in cancer patients.
Cardiovascular incidents including LV dysfunction, heart failure (HF), severe arrhythmias …

Aims Anticancer therapies have extended the lives of millions of patients with malignancies,
but for some this benefit is tempered by adverse cardiovascular (CV) effects. Cardiotoxicity …

Cardiotoxic effects of chemotherapy and targeted drugs are ubiquitous and challenging in
the field of oncology therapeutics. The broad spectrum of toxicities ranging from ischemic …

Cancer treatment today employs a combination of chemotherapy, radiotherapy, and surgery
to prolong life and provide cure. However, many of these treatments can cause …

Cardiovascular toxicity is a potential short-or long-term complication of anticancer therapy.
Exposure to chemotherapy medications, primarily the anthracycline class, can lead to …

Cardiotoxicity is a common complication of many anti-cancer agents and it remains a major
limitation, strongly impacting the quality of life and the overall survival, regardless of the …

Progress in the detection and treatment of cancer has led to an impressive reduction in both
mortality and morbidity. Due to their mechanism of action, however, conventional …

Cardiotoxicity caused by chemotherapy is a concerning reality plaguing oncologists and
cardiologists. The coexistence of cancer and cardiovascular diseases in the same patient is …